<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Departamento de Salud</title>
<link href="https://hdl.handle.net/20.500.12412/4336" rel="alternate"/>
<subtitle/>
<id>https://hdl.handle.net/20.500.12412/4336</id>
<updated>2026-09-26T12:09:20Z</updated>
<dc:date>2026-09-26T12:09:20Z</dc:date>
<entry>
<title>Juramento de profesionales de la salud</title>
<link href="https://hdl.handle.net/20.500.12412/7400" rel="alternate"/>
<author>
<name>Machuca, Manuel</name>
</author>
<id>https://hdl.handle.net/20.500.12412/7400</id>
<updated>2026-09-09T21:00:14Z</updated>
<published>2026-09-08T00:00:00Z</published>
<summary type="text">Juramento de profesionales de la salud
Machuca, Manuel
El presente documento recoge el Juramento de los Profesionales de la Salud, un texto concebido para ser pronunciado de forma conjunta y solemne en las ceremonias de graduación de la facultad. &#13;
La creación de este juramento responde a la necesidad de proponer y dotar a las nuevas promociones de egresados de un marco ético renovado, adaptado a las realidades complejas del sistema sanitario contemporáneo, alineado con los valores de la excelencia académica y humana a los que aspiramos.
</summary>
<dc:date>2026-09-08T00:00:00Z</dc:date>
</entry>
<entry>
<title>Unveiling altered CD8 T-cell metabolism and homeostatic proliferation behind a low CD4/ CD8 ratio in ART-suppressed HIV individuals with normal CD4 recovery</title>
<link href="https://hdl.handle.net/20.500.12412/7397" rel="alternate"/>
<author>
<name>Garrido-Rodríguez, Vanesa</name>
</author>
<author>
<name>Bulnes-Ramos, Ángel</name>
</author>
<author>
<name>Olivas-Martínez, Israel</name>
</author>
<author>
<name>Pozo-Balado, María del Mar</name>
</author>
<author>
<name>Tejerina-Picado, Francisco</name>
</author>
<author>
<name>Gutiérrez, Félix</name>
</author>
<author>
<name>Marco-Sánchez, Cristina</name>
</author>
<author>
<name>Tiraboschi, Juan Manuel</name>
</author>
<author>
<name>Castillo-Navarro, Antonia</name>
</author>
<author>
<name>Bernal, Enrique</name>
</author>
<author>
<name>García-Guerrero, María C</name>
</author>
<author>
<name>Puertas, María C</name>
</author>
<author>
<name>Peraire, Joaquim</name>
</author>
<author>
<name>Rull, Anna</name>
</author>
<author>
<name>Martínez-Picado, Javier</name>
</author>
<author>
<name>Pacheco, Yolanda María</name>
</author>
<id>https://hdl.handle.net/20.500.12412/7397</id>
<updated>2026-08-30T21:00:32Z</updated>
<published>2025-09-08T00:00:00Z</published>
<summary type="text">Unveiling altered CD8 T-cell metabolism and homeostatic proliferation behind a low CD4/ CD8 ratio in ART-suppressed HIV individuals with normal CD4 recovery
Garrido-Rodríguez, Vanesa; Bulnes-Ramos, Ángel; Olivas-Martínez, Israel; Pozo-Balado, María del Mar; Tejerina-Picado, Francisco; Gutiérrez, Félix; Marco-Sánchez, Cristina; Tiraboschi, Juan Manuel; Castillo-Navarro, Antonia; Bernal, Enrique; García-Guerrero, María C; Puertas, María C; Peraire, Joaquim; Rull, Anna; Martínez-Picado, Javier; Pacheco, Yolanda María
Background: People living with chronic HIV (PLWH) show immune dysfunction, despite viral suppression and normal CD4 recovery, particularly those with low CD4/CD8 ratios. Subjacent cellular alterations of such a reliable marker of clinical progression remain elusive.&#13;
&#13;
Methods: Categorization by CD4/CD8 ratio after three year of therapy (R &lt; 0.8/R &gt; 1.2, n = 28/n = 24) and post-hoc reclassification by nadir-CD4 (N ≤ 350/N &gt; 350) were performed in PLWH achieving viral suppression and CD4 ≥ 500. CD4 T cell-associated viral reservoir, as well as metabolism-related gene expression, glucose uptake ability, relative telomere length (RTL), and thymic output for CD4 and CD8 T cells, were determined.&#13;
&#13;
Results: Patients with a CD4/CD8 ratio &lt; 0.8 exhibited reduced CD8 T-cell glucose uptake ability after stimulation (p = 0.007) and trends to shorter RTL (p = 0.093) and to larger CD4-associated viral reservoir (p = 0.068) than R &gt; 1.2. Differently, patients with nadir ≤350 exhibited altered CD4 and CD8 T-cell expression of metabolism-related genes, although no differences in glucose uptake ability, and shorter RTL in both cell subsets, but similar viral reservoir to patients with nadir &gt;350. Remarkably, viral reservoir and both CD4 and CD8 thymic output showed inverse associations (r = -0.623, p = 0.01 and r = -0.661, p = 0.038, respectively).&#13;
&#13;
Conclusion: A low CD4/CD8 ratio in chronic PLWH stands on a larger viral reservoir in CD4 T cells and metabolic alterations in CD8 T cells, probably related to its exhaustion and compromised effector functionality, and thymic output could contribute to such alterations. Patients with lower nadir-CD4 showed a resting-like CD4 phenotype and a metabolically active CD8 subset, without further viral reservoir extension. Persistence of low CD4/CD8 ratio and low nadir-CD4 counts seems to rely on different immune damage.
</summary>
<dc:date>2025-09-08T00:00:00Z</dc:date>
</entry>
<entry>
<title>Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients</title>
<link href="https://hdl.handle.net/20.500.12412/7396" rel="alternate"/>
<author>
<name>Cordero, Elisa</name>
</author>
<author>
<name>Bulnes-Ramos, Ángel</name>
</author>
<author>
<name>Aguilar-Guisado, Manuela</name>
</author>
<author>
<name>González-Escribano, Francisca</name>
</author>
<author>
<name>Olivas, Israel</name>
</author>
<author>
<name>Torre-Cisneros, Julián</name>
</author>
<author>
<name>Gavaldá, Joan</name>
</author>
<author>
<name>Aydillo, Teresa</name>
</author>
<author>
<name>Moreno, Asunción</name>
</author>
<author>
<name>Montejo, Miguel</name>
</author>
<author>
<name>Fariñas, María Carmen</name>
</author>
<author>
<name>Carratalá, Jordi</name>
</author>
<author>
<name>Muñoz, Patricia</name>
</author>
<author>
<name>Blanes, Marino</name>
</author>
<author>
<name>Fortún, Jesús</name>
</author>
<author>
<name>Suárez-Benjumea, Alejandro</name>
</author>
<author>
<name>López-Medrano, Francisco</name>
</author>
<author>
<name>Roca, Cristina</name>
</author>
<author>
<name>Lara, Rosario</name>
</author>
<author>
<name>Pérez-Romero, Pilar</name>
</author>
<id>https://hdl.handle.net/20.500.12412/7396</id>
<updated>2026-08-30T21:00:31Z</updated>
<published>2020-10-06T00:00:00Z</published>
<summary type="text">Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients
Cordero, Elisa; Bulnes-Ramos, Ángel; Aguilar-Guisado, Manuela; González-Escribano, Francisca; Olivas, Israel; Torre-Cisneros, Julián; Gavaldá, Joan; Aydillo, Teresa; Moreno, Asunción; Montejo, Miguel; Fariñas, María Carmen; Carratalá, Jordi; Muñoz, Patricia; Blanes, Marino; Fortún, Jesús; Suárez-Benjumea, Alejandro; López-Medrano, Francisco; Roca, Cristina; Lara, Rosario; Pérez-Romero, Pilar
Introduction: Our goal was to study whether influenza vaccination induced antibody mediated rejection in a large cohort of solid organ transplant recipients (SOTR).&#13;
&#13;
Methods: Serum anti-Human Leukocyte Antigen (HLA) antibodies were determined using class I and class II antibody-coated latex beads (FlowPRATM Screening Test) by flow cytometry. Anti-HLA antibody specificity was determined using the single-antigen bead flow cytometry (SAFC) assay and assignation of donor specific antibodies (DSA) was performed by virtual-crossmatch.&#13;
&#13;
Results: We studied a cohort of 490 SOTR that received an influenza vaccination from 2009 to 2013: 110 (22.4%) received the pandemic adjuvanted vaccine, 59 (12%) within the first 6 months post-transplantation, 185 (37.7%) more than 6 months after transplantation and 136 (27.7%) received two vaccination doses. Overall, no differences of anti-HLA antibodies were found after immunization in patients that received the adjuvanted vaccine, within the first 6 months post-transplantation, or based on the type of organ transplanted. However, the second immunization dose increased the percentage of patients positive for anti-HLA class I significantly compared with patients with one dose (14.6% vs. 3.8%; P = 0.003). Patients with pre-existing antibodies before vaccination (15.7% for anti-HLA class I and 15.9% for class II) did not increase reactivity after immunization. A group of 75 (14.4%) patients developed de novo anti-HLA antibodies, however, only 5 (1.02%) of them were DSA, and none experienced allograft rejection. Only two (0.4%) patients were diagnosed with graft rejection with favorable outcomes and neither of them developed DSA.&#13;
&#13;
Conclusion: Our results suggest that influenza vaccination is not associated with graft rejection in this cohort of SOTR.
</summary>
<dc:date>2020-10-06T00:00:00Z</dc:date>
</entry>
<entry>
<title>Evaluation of a non-invasive screening approach to determine hepatitis E virus status of pig farms</title>
<link href="https://hdl.handle.net/20.500.12412/7395" rel="alternate"/>
<author>
<name>Risalde, María A</name>
</author>
<author>
<name>Rivero-Juárez, Antonio</name>
</author>
<author>
<name>Frías, Mario</name>
</author>
<author>
<name>Olivas, Israel</name>
</author>
<author>
<name>López-López, Pedro</name>
</author>
<author>
<name>García-Bocanegra, Ignacio</name>
</author>
<author>
<name>Brieva, Teresa</name>
</author>
<author>
<name>Caballero-Gómez, Javier</name>
</author>
<author>
<name>Camacho, Ángela</name>
</author>
<author>
<name>Fernández-Molera, Vicente</name>
</author>
<author>
<name>Gómez-Villamandos, José Carlos</name>
</author>
<author>
<name>Rivero, Antonio</name>
</author>
<id>https://hdl.handle.net/20.500.12412/7395</id>
<updated>2026-08-30T21:00:35Z</updated>
<published>2020-10-03T00:00:00Z</published>
<summary type="text">Evaluation of a non-invasive screening approach to determine hepatitis E virus status of pig farms
Risalde, María A; Rivero-Juárez, Antonio; Frías, Mario; Olivas, Israel; López-López, Pedro; García-Bocanegra, Ignacio; Brieva, Teresa; Caballero-Gómez, Javier; Camacho, Ángela; Fernández-Molera, Vicente; Gómez-Villamandos, José Carlos; Rivero, Antonio
Background Identifying pig farms infected with hepatitis E virus (HEV) is a key aspect to implement surveillance&#13;
programmes for this emerging zoonotic agent. Detection of HEV in blood has several drawbacks, including&#13;
animal handling, economic costs and animal stress. The objective of this study was to evaluate the effectiveness&#13;
of a non-invasive&#13;
screening approach for determining the HEV status of pig farms under different management&#13;
systems.&#13;
Methods Forty stool samples randomly collected from the pen floor of 17 intensive pig farms and the yard of&#13;
nine extensive ones were tested for HEV RNA. The invasive method used to confirm the HEV status of the farm&#13;
was HEV RNA analysis of serum samples randomly collected from 40 animals on each farm.&#13;
Results Twenty-one&#13;
HEV-positive&#13;
farms were detected by invasive and non-invasive&#13;
methods. No positive serum&#13;
or stool samples were detected on five intensive farms. A high intertest agreement (K=1; P&lt;0.00001) was observed&#13;
between both methodologies, showing the stool screening approach a 100 per cent of sensitivity and specificity&#13;
with respect to the invasive method. Likewise, a significant negative relationship was observed between the HEV&#13;
within-farm&#13;
prevalence and the number of the first HEV-positive&#13;
stool sample found (Spearman’s rho=−0.64;&#13;
P=0.0004). This negative relationship was higher in intensively managed farms.&#13;
Conclusion This non-invasive&#13;
screening approach could be reliably applied in a large-scale&#13;
surveillance&#13;
programme for determining the HEV status of pig farms under different management systems.
</summary>
<dc:date>2020-10-03T00:00:00Z</dc:date>
</entry>
</feed>
